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Altered lipid metabolism in macrophages is associated with various important
inflammatory conditions. Although lipid metabolism is an important target for
therapeutic intervention, the metabolic requirement involved in lipid accumulation
during pro-inflammatory activation of macrophages remains incompletely characterized.
We show here that macrophage activation with IFNγ results in increased aerobic
glycolysis, iNOS-dependent inhibition of respiration, and accumulation of triacylglycerol.
Surprisingly, metabolite tracing with 13C-labeled glucose revealed that the glucose
contributed to the glycerol groups in triacylglycerol (TAG), rather than to de novo synthesis
of fatty acids. This is in stark contrast to the otherwise similar metabolism of cancer cells,
and previous results obtained in activated macrophages and dendritic cells. Our results
establish a novel metabolic pathway whereby glucose provides glycerol to the headgroup
of TAG during classical macrophage activation.
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INTRODUCTION
Activation of macrophages with pro-inflammatory stimuli, also known as classical M1 activation,
induces a profound shift in energetic metabolism characterized by aerobic glycolysis and decreased
mitochondrial substrate oxidation (1, 2). Lipid accumulation is another salient metabolic feature
of phagocyte activation during infection and sterile inflammation (3, 4). During these conditions,
lipids accumulate in single membrane organelles known as lipid droplets or lipid bodies (5–7).
Lipid droplets originate from endoplasmic reticulum and contain a core of neutral lipid, namely
triacylglycerol (TAG) and cholesterol ester (8–10). Lipids contained within lipid droplets can be
used as substrate for ATP synthesis through β-oxidation and as precursors for membrane lipids,
eicosanoids, and nuclear receptor ligands (11–14).
While lipid accumulation in phagocytes is a hallmark of infection and sterile inflammation,
its underlying biosynthesis pathways are still unclear. Tracing studies of radiolabeled substrate
incorporation into total cellular lipids suggest that de novo fatty acid synthesis from glucose
contributes to lipid accumulation in macrophages in murine models of sterile inflammation
(15, 16), and in classically-activated macrophages and dendritic cells in vitro (11, 16, 17). However,
this approach does not provide information regarding the site of carbon incorporation, i.e., lipid
headgroup vs. fatty acid. On the other hand, lipids contained in lipoproteins are taken up by
macrophages leading to the formation of cytoplasmic lipid inclusions characteristic of “foam cells”
in the atherosclerotic plaque (18, 19). Thus, the question remains as to whether lipids accumulating
during classical macrophage activation originate from de novo fatty acid synthesis or from an
exogenous source of lipid.
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We show here that activation of macrophages with interferon
gamma (IFNγ), a major mediator of sterile and bacterial-
induced inflammation, increases glucose uptake and lactate
release. Further, IFNγ increases total TAG levels, and induces
lipid droplet accumulation that depends on exogenous lipids.
Metabolite tracing with 13C-labeled substrates revealed that de
novo synthesis of fatty acid from glucose plays a minor role, if at
all, in TAG accumulation. Rather, glucose provides to the glycerol
headgroup of TAG, while the acyl chains of TAG originate from
exogenous fatty acid (FA). Finally, we show that nitric oxide
produced by inducible nitric oxide synthase (iNOS) inhibits
mitochondrial respiration and therefore oxidation of FA, which
instead accumulates in lipid droplets.
RESULTS
Maf-DKO Cells Polarize to M1 and M2
Phenotypes
In order to study the metabolic basis of lipid droplet
accumulation, we used IFNγ to activate MafB/c-Maf double
deficient (Maf-DKO) primary mouse macrophages. These cells
are a bona fide alternative to other macrophage sources such
as RAW cells as they are not transformed cells with distorted
metabolism typical of cancer cells; maintain a differentiated
macrophage phenotype when expanded in culture; and
functionally integrate into tissues without causing tumors
when transplanted into mice (20, 21). Activation with IFNγ
led to expression of inducible nitric oxide synthase (iNOS) and
production of TNF whereas IL-4 led to arginase-1 expression
and failed to induce TNF production (Figures S1A,B). IFNγ also
increased the expression of the class II major histocompatibility
(MHC II) molecule I-A/I-E and CD86 (Figures S1C,D)
consistent with classical M1 macrophage activation (22–24).
Thus, Maf-DKO cells polarize to M1 and M2 phenotypes when
activated with IFNγ and IL-4, respectively.
IFNγ Induces Lipid Droplet and
Triacylglycerol Accumulation
IFNγ induced a 2-fold increase in glucose uptake rate and a
2-fold increase in lactate release rate (Figure 1A). Moreover,
oxygen consumption rate (OCR) decreased by 75% with
IFNγ. Inhibition of ATP synthase with oligomycin reduced
oxygen consumption in non-activated macrophages, indicating
coupling of oxygen consumption with ATP production. Instead,
oligomycin barely reduced the already decreased OCR in
macrophages activated IFNγ indicating that mitochondria
were producing few or no ATP. In non-activated macrophages,
uncoupling of oxidative phosphorylation from ATP synthesis
with the ionophore carbonyl cyanide 3-chlorophenylhydrazone
(CCCP) increased OCR, as expected in cells with intact
mitochondrial function in order to maintain the mitochondrial
membrane potential. The difference between the basal OCR and
CCCP-induced increase in OCR (spare respiratory capacity)
was completely abolished in macrophages activated with
IFNγ, suggesting mitochondrial dysfunction (Figure 1B).
Staining with LipidTOX, a fluorescent dye specific to neutral
lipids, showed round cytoplasmic organelles whose numbers
almost tripled upon activation with IFNγ (Figure 1C). These
LipidTOX-positive organelles were surrounded by the adipose
differentiation-related protein (ADRP, also known as perilipin
2 or adipophilin), a marker of lipid droplets (25) (Figure 1D).
Quantification of LipidTOX staining by flow cytometry
indicated a 3-fold increase in fluorescence intensity upon
activation with IFNγ, indicating a net increase in neutral lipid
content rather than the mere redistribution of the existing
neutral lipid pool (Figure 1E). This was supported by a
3-fold increase in TAG content in IFNγ-activated cells as
measured by an enzymatic colorimetric assay in total lipid
extracts (Figure 1F). Activation with IFNγ thus induces a
metabolic phenotype typical of classical macrophage activation
characterized by increased glycolysis, inhibition of respiration,
and TAG accumulation.
Glucose Provides Carbon to the Glycerol
Headgroup of Triacyglyclerol
Based on our observation of increased glucose uptake in
activated macrophages, we questioned if glucose contributed
to biosynthesis of TAG during lipid droplet formation. To
this end, we activated macrophages with IFNγ in medium
containing FCS, 0.8mM glutamine, and 4.8mM uniformly
labeled (U-)13C glucose. We then monitored 13C incorporation
into TAG using liquid chromatography-mass spectrometry (LC-
MS). We consistently observed a mass increase of 3 Da in
major TAG species extracted from cells activated in medium
containing U-13C glucose compared to TAG from cells activated
in medium containing unlabeled glucose (Figure 2A). Using
collision-induced fragmentation we confirmed that this 3 Da
mass increase was caused by exclusive 13C incorporation into
the glycerol headgroup of TAG that contains three carbons
(Figure 2B). Importantly, this mass shift is not compatible with
de novo fatty acid synthesis from glucose, which would have
resulted in various TAG isotopomers with mass increases in
multiples of 2, as fatty acids are synthesized by the sequential
addition of 2 carbon-units from acetyl-coenzyme A, and
carbons contained in acetyl-coenzyme A originating from U-
13C glucose are fully labeled (26). Similarly, we observed a
mass increase of 3 Da in phosphatidylcholine (that contains
one glycerol moiety) extracted from cells activated in medium
containing U-13C glucose compared to phosphatidylcholine
from cells activated in medium containing unlabeled glucose
(Figure S2), indicating that glucose provides the glycerol moiety
in the glycerophospholipid synthesis pathway. Moreover, the
activity of cytoplasmic glycerol 3-phosphate (cG3PDH) that
catalyzes the reaction dehydroxyacetone phosphate to glycerol
3-phosphate was decreased and the levels of glycerol 3-
phosphate were increased 24 h after activation (Figure S3),
providing further evidence of flow of glucose-derived carbon
through the common TAG and glycerophospholipid synthesis
pathway in macrophages activated with IFNγ. Finally, fatty
acid analyses confirmed that the 13C label from glucose
was not incorporated into the total fatty acid pool in
activated cells (Figure 2C). Our results thus suggest that
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FIGURE 1 | IFNγ up-regulates glucose uptake and lactate release, inhibits respiration, and induces triacylglycerol and lipid droplet accumulation. Maf-DKO
macrophages were incubated for 24 h in the presence or absence of IFNγ (10 ng/mL). (A) Glucose uptake and lactate release rates were obtained after 24 h of
incubation with or without IFNγ by measuring metabolite concentration in supernatants sampled hourly over a period of 3 h. Data shown as mean ± SEM of three
replicates. Data is representative of three experiments. (B) OCR under basal conditions and after sequential addition of oligomycin (Oligo), carbonyl cyanide
m-chlorophenyl hydrazine (CCCP), and rotenone plus antimycin (Rot/Ant). Data shown as mean ± SEM of six replicates. Data is representative of three experiments.
(C) Confocal fluorescence image of cells stained with LipidTOX and DAPI, and quantification of LipidTOX-positive organelles. Data shown as mean ± SEM of three
replicates from a single experiment. Scale bar 12.5µm. (D) Confocal fluorescence image of cells activated with IFNγ stained with DAPI, LipidTOX, and anti-ADRP
(perilipin 2) antibody. Scale bar 2.5µm. (E) Histogram and quantification of the mean fluorescence intensity (MFI) of cells stained with LipidTOX. Data shown as mean
± SEM of three replicates. Data is representative of three experiments. (F) Total cell triacylgylcerol (TAG) content. Data shown as mean ± SEM of four replicates from a
single experiment. **p < 0.01; ***p < 0.001.
glucose is not a relevant substrate for de novo synthesis
of fatty acid contained in TAG of macrophages activated
with IFNγ, but instead provides glycerol to the headgroup
of TAG.
Exogenous Lipids Are Required for Neutral
Lipid Accumulation Upon Activation With
IFNγ
We next investigated the source of lipids that IFNγ-activated
macrophages utilized to increase neutral lipid levels. To
determine the role of de novo fatty acid synthesis, we activated
macrophages in the presence of the fatty acid synthase (27)
inhibitor C75 at doses previously shown to inhibit FAS activity
(28–30). C75 failed to reduce LipidTOX fluorescence and did not
prevent lipid droplet formation in IFNγ-activated macrophages
(Figures 3A,B). Since glutamine is rapidly degraded in culture
medium, it was still possible that de novo fatty acid synthesis from
glutamine-derived carbon could play a role in TAG synthesis in
the presence of higher concentrations of glutamine. We did not
observe mass shifts in major TAG species extracted from cells
activated in medium containing 4mM U-13C, U-15N glutamine
compared to TAG from cells activated in medium containing
unlabeled glutamine (Figure S4), suggesting that glutamine is not
a relevant substrate for de novo synthesis of fatty acid contained
in TAG. As observed with low (4.8mM) glucose concentration,
there were mass shifts of 3 Da in major TAG species extracted
from cells activated in medium containing 24mMU-13C glucose
(Figure S4). Together, these data further support the notion
that de novo fatty acid synthesis was not required for neutral
lipid accumulation.
We next tested the role of exogenous lipids by activating
macrophages in delipidated serum in the presence or absence of
a lipid mixture containing fatty acids and cholesterol. Addition
of lipid mixture to delipidated serum, but not delipidated serum
alone, induced lipid droplet formation and increased LipidTOX
levels in IFNγ-activated cells (Figures 3C,D). We tested whether
this observation was applicable to other macrophage sources
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FIGURE 2 | Metabolic fate of 13C-glucose in TAG. (A) ToF-MS profile of major TAG species in macrophages activated in medium containing unlabeled or U-13C
glucose. A mass shift of 3 Da was observed in TAG species of macrophages activated in the presence of labeled glucose. (B) MS/MS of 52:2 TAG (m/z 876.5), a
major TAG species. A mass shift of 3 Da remains after loss of fatty acid chains induced by collision fragmentation in macrophages activated in the presence of labeled
glucose. (C) Fatty acid profile obtained from macrophages activated in medium containing unlabeled and U-13C glucose. There was no mass shift observed in fatty
acids obtained from macrophages activated in medium containing U-13C glucose. Data is representative of three experiments.
other than Maf-DKO cells. Indeed, activation of bone marrow-
derived macrophages with IFNγ induced lipid accumulation that
was also dependent on external lipids (Figure 3E).
To trace the fate of external lipids, we activated cells with IFNγ
in the presence of delipidated serum supplemented with a 12-
carbon long fatty acid analog labeled with the fluorescent dye
BODIPY (henceforth BODIPY-fatty acid). BODIPY-fatty acid
accumulated within lipid droplets, suggesting that exogenous
fatty acid incorporated into TAG contained in these organelles
(Figure 3F). We confirmed this by activating cells in the
presence of U-13C oleic acid. This resulted in TAG mass
increases in multiples of 18 as determined by LC-MS, indicating
incorporating one or several U-13C oleic acid chains into
TAG (Figure 3G).
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FIGURE 3 | Lipid droplet accumulation induced by IFNγ is dependent on exogenous lipids not de novo fatty acid synthesis. (A) LipidTOX MFI and (B) confocal
fluorescence image of Maf-DKO macrophages activated with IFNγ and incubated in the absence or presence of indicated concentrations of C75. Data shown as
(Continued)
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FIGURE 3 | mean ± SEM of three replicates. Data is representative of three experiments. Scale bar 12.5µm. (C) LipidTOX MFI and (D) confocal fluorescence image
of Maf-DKO macrophages incubated in the presence or absence of IFNγ in medium containing delipidated (Delip) FCS, or delipidated FCS plus lipid mixture. Data
shown as mean ± SEM of three replicates. Data is representative of three experiments. Scale bar 12.5µm. (E) LipidTOX MFI of bone marrow-derived macrophages
incubated in the presence or absence of IFNγ in medium containing delipidated (Delip) FCS, or delipidated FCS plus lipid mixture. Data shown as mean ± SEM of
three replicates. Data is representative of two experiments. (F) Confocal fluorescence image of cells activated with IFNγ for 24 h in medium containing delipidated
serum and BODIPY-fatty acid; scale bar 2.5µm. Cells were stained with DAPI and anti-ADRP antibody. (G) ToF-MS profile of TAG extracted from macrophages
activated in medium containing unlabeled or U-13C oleic acid. Note a mass shift of 36 and 54 in 52:2 TAG and 54:3 TAG, respectively, corresponding to incorporation
of 2 or 3 oleic-acid chains into TAG. Data is from a single experiment. (H) Confocal fluorescence image of cells before and after 10min incubation with delipidated
serum and BODIPY-fatty acid. Cells were previously activated with IFNγ for 24 h followed by a 30min incubation with triacsin (1µM). Yellow, BODIPY-fatty acid;
magenta, ADRP; scale bar 2.5µm. Image is representative of two experiments. (I) LipidTOX MFI of cells activated with IFNγ in the presence of indicated
concentrations of triacsin. Data shown as mean ± SEM of three replicates. Data is representative of two experiments. (J) LipidTOX MFI of cells incubated with or
without IFNγ for different time periods. (K) BODIPY-fatty acid incorporation into cells measured over 30min. (L) Area under the curve of BODIPY-fatty acid
incorporation of cells incubated in the presence or absence of IFNγ for the indicated time periods. Data shown as mean ± SEM of five replicates. Data is
representative of two experiments. ns, not significant; *p < 0.05; **p < 0.01; ***p < 0.001.
Externally derived fatty acids must be activated before
incorporation into TAG by esterification with coenzyme
A through a reaction catalyzed by fatty acyl-CoA synthetase.
Indeed, the fatty acid CoA synthetase inhibitor triacsin prevented
BODIPY-fatty acid accumulation in lipid droplets (Figure 3H),
reduced LipidTOX fluorescence intensity (Figure 3I), and
prevented lipid droplet formation (Figure S5), indicating
that fatty acid esterification with coenzyme A is needed
for fatty acid incorporation into lipid droplets in activated
macrophages. Together, these data demonstrate that neutral
lipids accumulating in activated macrophages originate from
glucose-derived glycerol as well as directly incorporated
externally-derived fatty acids, with no need for de novo fatty
acid synthesis.
Inhibition of Mitochondrial Respiration by
iNOS-Derived Nitric Oxide Induces Neutral
Lipid Accumulation
Lipid droplets might have accumulated because of increased fatty
acid uptake. We observed increased expression of the scavenger
receptor CD36 upon activation with IFNγ, but addition of
a blocking anti-CD36 antibody previously shown to inhibit
fatty acid uptake (31) did not diminish the LipidTOX increase
induced by IFNγ (Figure S6). In fact, despite continuously
increasing LipidTOX fluorescence over a period of 24 h
in activated macrophages (Figure 3J), we did not observe
differences in BODIPY-fatty acid incorporation rate between
activated and non-activated macrophages at any time point
studied (Figures 3K,L). Thus, neutral lipid accumulation in
IFNγ-activated macrophages is not accounted for by increased
uptake of fatty acid. Instead, the fate of internalized fatty acids
might differ between activated and non-activated macrophages.
To gain additional insight into the underlying metabolic
program required for lipid droplet accumulation we used
quantitative proteomics. We identified 2,865 proteins, out of
which 98 were differentially abundant (63 up, 35 down; FDR
q < 0.1, fold change > 2; Table S1). Proteins pertaining
to the electron transport chain complexes I and II were
down-regulated (2- to 2.9-fold change; Table S2; Figure S7).
In order to detect small but coordinated changes in the
expression of proteins belonging to predefined pathways, we
used the gene set enrichment analysis (GSEA) algorithm
(32) on our proteomics dataset. Results showed coordinated
up- or downward changes in the expression of proteins
belonging to 12 pathways (FDR q < 0.05) (Table S3). The
pathways with the two highest enrichment scores associated
with proteins up-regulated by IFNγ were the “Proteasome”
(normalized enrichment score, NES 2.159) and the “Antigen
and presentation” (NES 2.139) pathways, further supporting a
normal response of Maf-DKO macrophages to IFNγ. Metabolic
pathways associated with IFNγ up- or down-regulated proteins
were the “Glycolysis/gluconeogenesis” pathway (NES 1.719),
and the “Oxidative phosphorylation” pathway (NES −1.792),
respectively (Figures S8A,B), consistent with our results of
increased glycolysis and decreased OCR. The coordinated down-
regulation of proteins pertaining to oxidative phosphorylation
observed in our proteomics dataset, together with published
research that inhibition of mitochondrial β-oxidation can lead
to lipid droplet accumulation under a continued supply of fatty
acid (33–35), hinted at impaired mitochondrial respiration as
the underlying mechanism for accumulation of neutral lipids in
macrophages activated with IFNγ.
To test this possibility, we first determined macrophage
β-oxidation activities under basal conditions. Incubation of
macrophages for 24 h with the carnitine palmitoyltransferase I
inhibitor etomoxir reduced OCR by 23.5 ± 0.4% (Figure 4A),
which is equivalent to 65.7 ± 4.8 pmoles per minute per million
cells (Table S4). This accounts for 30.3± 0.6% of the oligomycin-
sensitive OCR, indicating that mitochondrial fatty acid oxidation
accounts for 30.3% of the oxygen consumption coupled to ATP
production (Figure 4A). Based on our calculations (Table S4),
the estimated amount of fatty acid oxidized in mitochondria in
24 h by non-activated macrophages corresponds to 11.7 times
the amount of TAG accumulated by macrophages activated with
IFNγ over the same period of time, assuming total incorporation
of fatty acid exclusively into TAG. This relatively high level of
β-oxidation under basal conditions suggested that even partial
inhibition of mitochondrial fatty acid oxidation could fully
account for the accumulation of TAG observed in macrophages
activated with IFNγ. In line with this, etomoxir induced a small
but statistically significant increase in LipidTOX fluorescence
intensity in non-activated cells incubated in medium containing
delipidated serum supplemented with lipid mixture (Figure 4B).
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FIGURE 4 | Inhibition of mitochondrial respiration by iNOS induces lipid droplet accumulation. (A) Maf-DKO macrophages were incubated for 24 h in medium
containing FCS plus or minus etomoxir (200µM) or oligomycin (10µM). Oxygen consumption rate (OCR) was then measured in the presence of drug. Three
consecutive basal OCR measurements were averaged. Data shown as mean ± SEM of triplicates, and is representative of two experiments. (B,C) LipidTOX MFI of
cells incubated in medium with delipidated FCS plus or minus lipid mixture, with or without etomoxir (200µM) or oligomycin (10µM). Data shown as mean ± SEM of
3 replicates. Data is representative of two experiments. (D) OCR of cells incubated for 24 h without or with IFNγ plus DETA/NO (100µM). Three consecutive basal
OCR measurements were averaged. Data shown as mean ± SEM of triplicates, and is representative of two experiments. (E) LipidTOX MFI levels in cells incubated in
medium containing delipidated FCS plus or minus lipid mixture, with or without DETA/NO (100µM). Data shown as mean ± SEM of triplicates, and is representative of
two experiments. (F) Cells were incubated for 24 h without or with IFNγ plus SEITU (500µM). OCR was then measured before and after sequential addition of
oligomycin, CCCP and rotenone plus antimycin. The blue trace shows OCR of cells in which etomoxir (200µM) was added after 24 h of incubation with IFNγ plus
SEITU, and 30min before measurements started to be obtained. (G) LipidTOX MFI levels in cells incubated in FCS without or with IFNγ plus indicated concentrations
of SEITU. Data shown as mean ± SEM of triplicates, and is representative of two experiments. (H) Histogram and quantification of Mitosox MFI in Maf-DKO cells
incubated for 24 h with or without IFNγ or with IFNγ plus SEITU (S) (500µM). Data shown as mean ± SEM of triplicates, and is representative of two experiments. ns,
not significant *p < 0.05; **p < 0.01; ***p < 0.001. (I) Model of metabolic changes leading to TAG accumulation in activated macrophages. Macrophages oxidize fatty
acid under basal conditions. Upon activation with IFNγ, nitric oxide produced by INOS inhibits mitochondrial respiration, and as a consequence, β-oxidation. External
fatty acid that would otherwise be oxidized in mitochondria is esterified with glycerol 3-phosphate originating from glucose leading to synthesis of TAG and its
accumulation in lipid droplets. Numbers in red indicate the inhibition site of the following compounds: 1, etomoxir: inhibits carnitine palmitoyltransferase-1; 2,
oligomycin: inhibits ATP synthase; 3, DETA/NO: inhibits respiratory complexes I and IV; 4, SEITU: inhibits iNOS; 5, triacsin: inhibits fatty acyl-CoA synthetase.
Importantly, etomoxir failed to increase LipidTOX fluorescence
intensity and to induce lipid droplet formation in cells incubated
without lipid mixture (Figure 4B; Figure S9A). Moreover,
inhibition of mitochondrial respiration with the ATP synthase
inhibitor oligomycin also increased LipidTOX fluorescence
intensity and induced lipid droplet formation in non-activated
cells (Figure 4C; Figure S9B). As with etomoxir, the increase in
LipidTOX fluorescence intensity and lipid droplet accumulation
induced by oligomycin was dependent on exogenous lipids
(Figure 4C; Figure S9B). Taken together, these findings indicate
that macrophages oxidize fatty acid under basal conditions,
and that inhibition of fatty acid oxidation or mitochondrial
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respiration is sufficient to increase neutral lipid content in non-
activated macrophages, provided exogenous lipids are available.
Next, we tested if inhibition of mitochondrial respiration
by nitric oxide contributed to accumulation of neutral lipid
upon activation with IFNγ (36, 37). We incubated non-
activated macrophages with the nitric oxide donor molecule
diethylenetriamine/NO adduct (DETA/NO) for 24 h (38, 39).
DETA/NO significantly decreased OCR (Figure 4D), increased
LipidTOX fluorescence intensity and induced lipid droplets
in cells incubated in medium containing delipidated serum
complemented with lipid mixture, but not without (Figure 4E;
Figure S9C). Conversely, SEITU, a selective iNOS inhibitor,
partially reversed the OCR inhibition induced by IFNγ and
completely recovered mitochondrial spare respiratory capacity
(Figure 4F). SEITU also induced a partial but significant
dose-dependent reduction in LipidTOX fluorescence intensity
and lipid droplets (Figure 4G; Figure S10). Notably, etomoxir
reduced OCR even when added to cells after 24 h of incubation
with IFNγ plus SEITU (Figure 4F), indicating that SEITU
preserved the capacity of mitochondria to perform β-oxidation,
even in macrophages activated with IFNγ. This finding further
supports the notion that neutral lipids accumulate due to reduced
mitochondrial oxidation of fatty acid. Activation with IFNγ
also increased mitochondrial reactive oxygen species (mROS)
levels, an indicator of mitochondrial damage (40). Macrophage
activation in the presence of SEITU significantly reduced mROS
levels (Figure 4H), suggesting that SEITU inhibited neutral
lipid accumulation by preventing mitochondrial damage and
thus preserving fatty acid oxidation in mitochondria. Altogether
these data indicate that iNOS-derived nitric oxide inhibits
mitochondrial respiration, and as a consequence, fatty acid
oxidation, leading to neutral lipid accumulation that is dependent
on exogenous lipids.
DISCUSSION
Inspired by lipid metabolism of cancer cells, the current model
of classical M1 activation of macrophages assumes a switch from
fatty acid degradation to de novo fatty acid synthesis. In order to
study the contribution of metabolites to lipid synthesis, previous
studies have relied on the detection of radioactivity in total lipids
extracted from cells incubated in the presence of 14C-labeled
glucose (11, 17, 41, 42). Based on these data, it was proposed
that fatty acid is synthesized de novo from glucose-derived carbon
in classically-activated macrophages and dendritic cells (11, 17).
However, this approach is non-informative about the site of
carbon incorporation, i.e., lipid headgroup vs. fatty acid, and
thus no proof for fatty acid biogenesis. In the present study,
we revisited this issue using current lipidomics techniques. We
could confirm incorporation of carbon derived from glucose
into macrophage lipids but, surprisingly, this was exclusively
restricted to the glycerol moiety in the headgroup of TAG,
but not fatty acids. The lack of any impact of blocking FAS
by C75 confirmed no need for fatty acid de novo synthesis. It
remains possible however that glucose contributes carbon for
synthesis of other lipid species, for example through citrate in the
mevalonate pathway. Instead, carbon atoms in the acyl chains of
TAG derive largely from exogenous fatty acids, and neutral lipid
accumulation is indeed dependent on exogenous lipids and their
activation by esterification with coenzyme A.
In non-activated macrophages, exogenous lipids are taken
up at similar rates compared to activated cells. However, non-
activated macrophages degrade lipids by β-oxidation, whereas
β-oxidation is blocked in activated macrophages. This is in
part due to generation of iNOS-derived nitric oxide, which can
directly or through reactive nitrogen species inhibit oxidative
phosphorylation through S-nitrosylation of protein cysteine
residues of respiratory complexes I and IV (43, 44). Inhibition
of oxidative phosphorylation could also be accounted for by
itaconate-induced inhibition of SDH, a mechanism known to
occur in activated macrophages (45). In addition, our proteome
dataset indicates copy number reduction of multiple proteins
involved in the mitochondrial respiratory chain, suggestive of
loss of mitochondrial mass. Such reduction of mitochondrial
content can be caused by mitophagy, the selective degradation
of damaged mitochondria through autophagy. Indeed, IFNγ
induces autophagy in macrophages (46), and our own results
show that IFNγ increases mROS levels, both indications for
damaged mitochondria (47, 48). It is this block in respiration
that prevented degradation of fatty acids by β-oxidation. This
diminished fatty acid catabolism, but not de novo biogenesis of
fatty acids, is the basis of lipid accumulation in macrophages
activated with IFNγ (Figure 4I).
Increased glucose uptake is a hallmark of macrophage
pro-inflammatory activation. High glucose uptake supports
phagocyte function by maintaining high ATP synthesis rates
through glycolysis, and provides reduction potential through
the pentose phosphate pathway (21, 49). We show now that
glucose also contributes carbon specifically to the glycerol
headgroup of TAG. In the glycerolipid synthesis pathway,
the glycolytic intermediate dihydroxyacetone phosphate is
reduced in the reaction catalyzed by cytoplasmic glycerol
3-phosphate dehydrogenase producing glycerol 3-phosphate.
Glycerol 3-phosphate is then acylated by glycerol 3-phosphate
acyltransferase, the rate limiting step of de novo TAG synthesis
(50). We propose that increased glycolysis rate also serves
to supply glycerol 3-phosphate for glycerolipid synthesis
in activated macrophages. This could serve the function
of decreasing levels of otherwise toxic fatty acids, and/or
of providing lipids to endoplasmic reticulum and Golgi
apparatus required for increased cytokine production, for
example (11, 51, 52).
In our study, macrophage activation underwent in
medium containing glucose and glutamine at physiological
concentrations. Nonetheless, lipids in tissue culture medium
do not necessarily represent qualitatively nor quantitatively the
lipid composition of plasma in vivo. This is particularly the case
in sterile and non-sterile systemic inflammation, conditions
characterized by abnormal plasma levels of lipoprotein and
TAG (53, 54). In contrast to our findings, previous studies
have failed to show increase in glucose uptake in resident
peritoneal macrophages activated with IFNγ plus TNF (55).
This discrepancy can be explained by functional differences
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between macrophage sources including the magnitude of their
responses to pro-inflammatory and anti-inflammatory stimuli
(56, 57). Macrophages can also be activated by other stimuli
including pathogen-associated molecular patterns (PAMPs) such
as LPS. It may be interesting to investigate in future studies if
similar metabolic activities drive lipid accumulation in activated
macrophages also under these conditions.
In conclusion, our findings establish a newmetabolic pathway
in activated macrophages in which exogenous fatty acids are the
primary source of acyl chains that are then esterified with de novo
synthesized glycerol from glucose yielding TAG. In comparison
to the previously assumed de novo fatty acid biosynthesis, this
pathway is a more efficient way to store lipids since it requires
minimal energy and overall metabolic activities. This lipogenesis
pathway is fundamentally different from that in cancer cells that
synthesize their own fatty acids from glutamine and glucose, and
highlights that metabolism of activated macrophages and cancer
cells might be more different than previously assumed.
MATERIALS AND METHODS
Cell Culture
MafB/c-Maf double deficient (Maf-DKO) macrophages were a
kind gift from Dr. Michael H. Sieweke (Center d’Immunologie
de Marseille-Luminy). Maf-DKO cells were grown in DMEM
containing 20% L929-conditioned medium and 10% FCS.
BMDM were differentiated from bone marrow cells obtained
from C57BL6 mice in the presence of DMEM containing 20%
L929-conditioned medium and 10% FCS. Maf-DKO cells were
predominantly octaploid (8c) whereas BMDM were diploid (2c)
and octaploid (8c) as determined by DNA quantification with
DAPI staining (data not shown). For experiments, cells were
incubated for 24 h at 37◦C and 5% CO2 in low glucose, low
glutaminemedium (henceforth LGLGmedium) which contained
DMEM, 44mM sodium bicarbonate, 10% FCS, glucose (4.8mM),
and glutamine (0.8mM) with or without IFNγ 10 ng/mL or IL-
4 10 ng/mL (both from Preprotec), and C75, etomoxir, triacsin,
oligomycin, DETA/NO, or SEITU (all from Sigma) at the
indicated concentrations. In a set of experiments, FCS was
replaced with delipidated serum (Lipoprotein deficient serum
from fetal calf, Sigma) plus a 1:100 dilution of lipid mixture
(Lipidmixture 1, Sigma) containing cholesterol, and arachidonic,
linoleic, linolenic, myristic, oleic, palmitic, and stearic acids.
Cell Surface Markers
Cells were incubated in 24-well plates for 24 h after which
they were washed once with cold PBS and detached with cold
PBS/EDTA 1mM. Cells were stained with anti-CD86 (BD, clone
GL1), I-A/I-E (BD, clone 2G9) or anti-CD36 (Merck, clone 63)
antibodies in FACS buffer (PBS, EDTA 2mM, 2% FCS) for 30min
on ice, washed once, and resuspended for cytometry analysis.
Cells were acquired with an LSRFortessa II flow cytometer (BD
Biosciences) and analyzed with FlowJo (Tree Star, Inc.).
Neutral Lipid Staining
Cells were incubated in 24-well plates for 24 h after which they
were washed once with cold PBS, fixed with PBS containing
formaldehyde 4% for 10min, and washed three times with PBS.
Cells were incubated at room temperature (RT) for 30min with
HCS LipidTOX Green Neutral Lipid (ThermoFisher Scientific)
diluted 1:1,000 in PBS, washed three times with PBS, scraped
off, and resuspended in PBS for flow cytometry analysis. For
microscopy analysis, cells were grown on microscope slides
inside wells of 24-well plates followed by the same procedure
as for flow cytometry with the addition of DAPI. For ADRP
staining, cells were incubated at RT for 1 h in blocking buffer
(PBS, 0.2% TritonX-100, 5% goat serum). Then, rabbit polyclonal
anti-ADRP antibody (Abcam) was added at a final 1:200 dilution,
and cells were incubated for 2 h at RT. After washing with
blocking medium, cells were incubated at RT for 2 h in blocking
medium containing Alexa Fluor 647-conjugated goat anti-
rabbit antibody (ThermoFisher Scientific) at a 1:1,000 dilution.
After washing with blocking medium, cells were mounted with
Fluoromount-G (Southern Biotech). Images were taken with a
Leica SP8 confocal microscope, and analyzed with Fiji.
Mitochondrial Reactive Oxygen Species
Cells were washed once with cold PBS. PBS was then removed
and cold PBS/EDTA 5µM solution was added. Cells were
incubated for 5min at RT, gently detached by pipetting, and
transferred to FACS tubes and kept on ice. Tubes were spun down
at 200 g for 5min at 4◦C, after which PBS/EDTA was removed.
Cells were resuspended in 200 µL of LGLG medium containing
2 µL of a 1:10 dilution of Mitosox (ThermoFisher Scientific),
and incubated at 37◦C in a water bath for exactly 25min. DAPI
was then added to exclude dead cells and cells were analyzed by
flow cytometry.
Metabolite and Cytokine Quantification
Glucose, lactate, and triacylglycerol were determined using
commercially available enzymatic assay kits (BioAssay Systems
or BioVision) following the manufacturers’ instructions. Glycerol
3-phosphate and activity of cG3PDH were quantified as
previously described (58, 59). Cytokines were measured using
the Cytometric Bead Array Flex Set system (BD Biosciences) and
analyzed with FlowJo (Tree Star, Inc.). Cytokine detection limits
are IL-1β: 1.9 pg/mL; IL-6: 1.4 pg/mL; IL-10: 9.6 pg/mL; and
TNF-α: 2.8 pg/mL.
Western Blot
Total cell protein was extracted from cells using CelLytic M
(Sigma) and kept at −20◦C until further analysis. Protein
was heated for 5min at 50◦C (for mitochondrial respiratory
complexes) or 95◦C (for iNOS and arginase-1) in 5x Laemmli
buffer containing 2-mercaptoethanol. Samples were loaded into
acrylamide gels and protein was transferred to PVDFmembranes
followed by detection with chemiluminiscence using the total
OXPHOS rodent WB antibody cocktail (Abcam), or anti-
INOS (Abcam, ab15323), anti-arginase-1 (Santa Cruz, sc-18354)
or anti-β-actin antibodies (Rockland Immunochemicals) plus
appropriate HRP-conjugated secondary antibodies.
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Oxygen Consumption Measurements
Oxygen consumption rate was measured with an XFe
Extracellular Flux Analyzer (Seahorse Bioscience). Cells
were incubated for 24 h in XF-96 cell culture plates at a density
of 105 cells/200 µL per well in LGLG medium in the presence
or absence of IFNγ 10 ng/mL, and SEITU, etomoxir, DETA-NO
and oligomycin at the indicated concentrations. One hour prior
to the experiment, LGLG medium was removed and 175 µL
of assay medium (LGLG medium containing 44mM sodium
chloride instead of 44mM sodium bicarbonate in order to
prevent pH buffering and to maintain medium osmolarity)
were added. Drugs (25 µL) were injected during the assay at
the following final concentrations: oligomycin (1µM), CCCP
(carbonyl cyanide m-chloro phenyl hydrazone) as uncoupler
(2µM), and rotenone (100 nM) plus antimycin (1µM). The
experiment was performed at 37◦C and 20% oxygen using a
mix-wait-measure protocol of 3-0-3min with three initial basal
rate measurements.
Fatty Acid Uptake
Fatty acid uptake was determined by measuring incorporation
of the fluorescent fatty acid analog C1-BODIPY 500/510-C12
(Life Technologies) into cells using a fluorescent plate reader,
as previously described (60). Briefly, cells were cultured for
24 h in LGLG medium in 96-well black plates with clear flat
bottom wells at a concentration of 105 cells per well in the
presence or absence of IFNγ 10 ng/mL. Cells were washed
once with warm PBS and incubated at 37◦C for 30min with
100 µL of LGLG without FCS (serum free LGLG medium).
Staining solution consisted of one part 2x serum free LGLG
medium plus one part 8% trypan blue that served as fluorescence
quencher. To this staining solution C1-BODIPY 500/510-C12
diluted 1:4,000 from a 1 mg/mL stock was added. Fatty
acid incorporation was started by adding 100 µL of pre-
warmed (37◦C) staining solution (final C1-BODIPY 500/510-
C12 concentration 309 nM) to each well already containing
100 µL of serum free LGLG. Fluorescence (Ex485/Em528) was
measured from the bottom of the plate on a Synergy H4 (BioTek)
plate reader set at 37◦C. Data were acquired at intervals of
80 s for up to 30min, time at which fluorescence plateaued.
In a different experiment, cells were incubated for 24 h in
LGLG medium containing delipidated serum, IFNγ 10 ng/mL
and C1-BODIPY 500/510-C12 at a final dilution of 1:4,000.
In another set of experiments, cells were incubated for 24 h
in LGLG medium containing FCS and IFNγ 10 ng/mL. Cells
were washed once with warm PBS, and incubated at 37◦C for
30min in LGLG medium containing delipidated serum plus
triacsin (1µM), after which C1-BODIPY 500/510-C12 was added.
After 10min of incubation at 37◦C cells were washed swith
PBS, fixed, and stained with DAPI and anti-ADRP antibody as
mentioned above.
Mass Spectrometry Analyses of Lipids
With 13C-Labeled Compounds
Cells were incubated in 6-well plates in the presence of
IFNγ 10 ng/mL in LGLG medium. Some wells contained
4.8mM uniformly-labeled (U-13C) glucose (Cambridge Isotope
Laboratories) instead of glucose. In another set of experiments,
cells were incubated in the presence of IFNγ 10 ng/mL inmedium
containing 24mM uniformly-labeled (U-13C) glucose plus L-
glutamine 4, or 24mM of glucose plus 4mM U-13C, U-15N
L-glutamine (Cambridge Isotope Laboratories). In another set
of experiments, cells were incubated in the presence of LGLG
containing delipidated serum instead of FCS plus 50µM oleic
acid or U-13C oleic acid (Sigma) conjugated to BSA. After 24 h,
cells were washed once with cold PBS, scraped off, counted,
resuspended in 100 µL of PBS, and kept frozen at −80◦C until
further analysis. For lipid extraction, cells were thawed and
extracted using modified Bligh and Dyer method (61). Samples
were kept frozen at −80◦C until further analysis. For fatty acid
analyses, lipids were hydrolyzed and derivatized using the AMP+
mass spectrometry kit (Cayman) according to the manufacturer’s
instructions. TAG analyses were performed using a SCIEX
tripleToF mass spectrometer (6600) coupled to an Agilent liquid
chromatography (1290) system. Separation of TAG was achieved
using a C18 column as previously described (62). For fatty acid
analysis, the derivatized fatty acids were directly infused into the
mass spectrometer and analyzed using ToF-MS scan.
Proteomics
Cells were incubated in the presence or absence of IFNγ for
24 h, after which they were washed three times with cold PBS.
They were then scrapped off, counted, spun down, resuspended
in PBS, and kept frozen at −80◦C until further quantitative
proteomic analysis as described previously (63). In brief, proteins
were extracted, reduced, alkylated, and digested using LysC
and trypsin. After desalting, peptide samples were analyzed
by nanoscale liquid chromatography-tandem mass spectrometry
(nLC-MS/MS) and identified by database searching against
all predicted proteins for Mus musculus downloaded from
SwissProt (2016/10/05). Proteins were quantified by MS1-based
label-free quantification and statistical analysis was performed
using SafeQuant (63). GSEA analysis (32) was performed using
1,000 sample permutations. Protein sets obtained from the
KEGG pathway database were tested for enrichment within our
proteome data set ranked according to the signal-to-noise metric.
Pathways identified in this way with a FDR q < 0.05 were
considered as discoveries.
Statistical Analysis
Comparisons between two groups were made using a two-
tailed unpaired t-test. Comparisons between three or more
groups were made using a one-way analysis of variance
with Bonferroni correction. P < 0.05 were considered
statistically significant. Analyses were performed with Prism
5 (GraphPad).
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